0
Inquiry Basket
Quote

Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

Cat# : VAC-0341

Product Datasheets COA :
Catalog# Product Name Availability Size Price Qty
VAC-0341 Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) July 20, 2024 0.5ml $1,998.00
Add to Cart Online Order Request a Bulk Order
Cat#:  VAC-0341
Product Name:  Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Description:  Ad5-nCoV is a recombinant adenovirus type-5 vector (Ad5) vaccine currently being investigated for prophylaxis against SARS-CoV-2.1,2 It is being developed by CanSino Biologics Inc., in partnership with the Beijing Institute of Biotechnology, who in March 2020 announced the approval of a phase I clinical trial (ChiCTR2000030906)1 with an expected completion in December 2020. The study will evaluate antibody response in healthy patients between the ages of 18 and 60 who will receive one of three study doses, with follow-up taking place at weeks 2 and 4 and months 3 and 6 post-vaccination.2
Biologic Classification:  Vaccines Recombinant
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry

  • Size: 100ug 500ug 1mg 5mg 10mg 100mg 500mg 1g
  • Conjugation: None R-PE APC Biotin FITC Alexa Flour Others
CONTACT US

For more information on how our products could help advance your project, please contact us.

Contact Us

ENTER YOUR EMAIL HERE TO SUBSCRIBE.

Copyright © 2024 Creative BioMart. All Rights Reserved.